• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.抗苗勒管激素诊断界值在中国女性多囊卵巢综合征中的应用。
PLoS One. 2018 Aug 28;13(8):e0203129. doi: 10.1371/journal.pone.0203129. eCollection 2018.
2
The Relevant Hormonal Levels and Diagnostic Features of Polycystic Ovary Syndrome in Adolescents.青少年多囊卵巢综合征的相关激素水平及诊断特征
J Clin Med. 2020 Jun 11;9(6):1831. doi: 10.3390/jcm9061831.
3
Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.血清抗苗勒管激素水平升高可作为多囊卵巢综合征的一种新的诊断标志物。
Acta Obstet Gynecol Scand. 2013 Dec;92(12):1369-74. doi: 10.1111/aogs.12247. Epub 2013 Oct 15.
4
Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.抗苗勒管激素和抑制素A,而非抑制素B或胰岛素样肽3,可作为青少年多囊卵巢综合征诊断的替代指标:初步结果
J Clin Res Pediatr Endocrinol. 2016 Sep 1;8(3):288-97. doi: 10.4274/jcrpe.3253. Epub 2016 Apr 29.
5
Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.血清抗苗勒管激素和抑制素B在预测多囊卵巢综合征患者卵巢反应中的临床价值
J Huazhong Univ Sci Technolog Med Sci. 2017 Feb;37(1):70-73. doi: 10.1007/s11596-017-1696-x. Epub 2017 Feb 22.
6
AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.抗缪勒管激素联合性激素结合球蛋白用于多囊卵巢综合征的诊断。
J Obstet Gynaecol. 2019 Nov;39(8):1130-1136. doi: 10.1080/01443615.2019.1587604. Epub 2019 Jun 17.
7
[A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].基于2012年中国多囊卵巢综合征诊断标准的血清抗苗勒管激素在多囊卵巢综合征诊断中的初步研究
Zhonghua Fu Chan Ke Za Zhi. 2015 Nov;50(11):819-24.
8
[Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].[促黄体生成素与促卵泡生成素比值对多囊卵巢综合征患者抗苗勒管激素分泌及卵泡发生的影响]
Zhonghua Fu Chan Ke Za Zhi. 2010 Aug;45(8):567-70.
9
Exploration of the role of anti-Mullerian hormone and LH/FSH ratio in diagnosis of polycystic ovary syndrome.探讨抗苗勒管激素和 LH/FSH 比值在多囊卵巢综合征诊断中的作用。
Clin Endocrinol (Oxf). 2019 Apr;90(4):579-585. doi: 10.1111/cen.13934. Epub 2019 Feb 10.
10
Advantages of Serum Anti-Müllerian Hormone as a Marker for Polycystic Ovarian Syndrome.血清抗苗勒管激素作为多囊卵巢综合征标志物的优势
Lab Med. 2019 Jul 16;50(3):236-242. doi: 10.1093/labmed/lmy068.

引用本文的文献

1
Effects of inulin on intestinal flora and metabolism-related indicators in obese polycystic ovary syndrome patients.菊粉对肥胖多囊卵巢综合征患者肠道菌群及代谢相关指标的影响。
Eur J Med Res. 2024 Aug 31;29(1):443. doi: 10.1186/s40001-024-02034-9.
2
Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis.抗缪勒管激素与多囊卵巢综合征胰岛素抵抗的相关性:系统评价和荟萃分析。
J Ovarian Res. 2024 May 18;17(1):106. doi: 10.1186/s13048-024-01436-x.
3
The Relationship Between Anti-Müllerian Hormone and Body Composition Components in Patients With Polycystic Ovary Syndrome of Reproductive Age.抗缪勒管激素与生殖年龄多囊卵巢综合征患者体成分的关系。
Reprod Sci. 2024 Sep;31(9):2843-2848. doi: 10.1007/s43032-024-01561-4. Epub 2024 Apr 23.
4
The Correlation between Sex Hormone-Binding Globulin and Clinical Characteristics According to Anti-Müllerian Hormone in Women with Regular Menstrual Cycles: A Prospective Study.月经周期规律女性中,性激素结合球蛋白与基于抗苗勒管激素的临床特征之间的相关性:一项前瞻性研究。
J Pers Med. 2024 Feb 29;14(3):274. doi: 10.3390/jpm14030274.
5
Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters.血清抗苗勒管激素(AMH)水平预测多囊卵巢综合征(PCOS)的效能及其与临床、生化和激素参数的关联。
Indian J Clin Biochem. 2023 Oct;38(4):457-465. doi: 10.1007/s12291-022-01058-4. Epub 2022 Sep 6.
6
Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS.血清抗苗勒管激素(AMH)水平在不同 PCOS 表型中的差异及其与 PCOS 的临床、内分泌和代谢标志物的相关性。
Reprod Sci. 2023 Aug;30(8):2554-2562. doi: 10.1007/s43032-023-01195-y. Epub 2023 Mar 2.
7
The Relationship Between Insulin Resistance and Obesity and Serum Anti-Mullerian Hormone Level in Chinese Women with Polycystic Ovary Syndrome: A Retrospective, Single-Center Cohort Study.中国多囊卵巢综合征女性胰岛素抵抗、肥胖与血清抗苗勒管激素水平的关系:一项回顾性单中心队列研究
Int J Womens Health. 2023 Feb 5;15:151-166. doi: 10.2147/IJWH.S393594. eCollection 2023.
8
A Meta-Analysis of Observational Studies on Prolactin Levels in Women with Polycystic Ovary Syndrome.多囊卵巢综合征女性催乳素水平观察性研究的Meta分析
Diagnostics (Basel). 2022 Nov 23;12(12):2924. doi: 10.3390/diagnostics12122924.
9
The alterations of circulating mucosal-associated invariant T cells in polycystic ovary syndrome.多囊卵巢综合征患者循环黏膜相关不变 T 细胞的改变。
Front Endocrinol (Lausanne). 2022 Nov 28;13:1038184. doi: 10.3389/fendo.2022.1038184. eCollection 2022.
10
Clinical Utilities of Anti-Müllerian Hormone.抗苗勒管激素的临床应用
J Clin Med. 2022 Dec 4;11(23):7209. doi: 10.3390/jcm11237209.

本文引用的文献

1
Anti-Müllerian hormone is a survival factor and promotes the growth of rhesus macaque preantral follicles during matrix-free culture.抗缪勒管激素是一种生存因子,可促进无基质培养恒河猴腔前卵泡的生长。
Biol Reprod. 2018 Feb 1;98(2):197-207. doi: 10.1093/biolre/iox181.
2
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.将血清抗苗勒管激素检测作为多囊卵巢形态的替代指标:对多囊卵巢综合征的诊断和表型分类的影响。
Hum Reprod. 2017 Aug 1;32(8):1716-1722. doi: 10.1093/humrep/dex239.
3
Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome.五种血清抗苗勒管激素检测方法对多囊卵巢综合征诊断的比较评估
Fertil Steril. 2016 Apr;105(4):1063-1069.e3. doi: 10.1016/j.fertnstert.2015.12.023. Epub 2016 Jan 6.
4
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.抗苗勒管激素在不同多囊卵巢综合征表型特征描述中的作用
Reprod Sci. 2016 May;23(5):655-61. doi: 10.1177/1933719115611751. Epub 2015 Dec 29.
5
Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients.抗苗勒管激素作为多囊卵巢综合征患者的诊断和预后工具。
J Assist Reprod Genet. 2014 Oct;31(10):1311-6. doi: 10.1007/s10815-014-0300-6. Epub 2014 Aug 14.
6
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.抗缪勒管激素:卵巢储备检测及其潜在的临床意义。
Hum Reprod Update. 2014 Sep-Oct;20(5):688-701. doi: 10.1093/humupd/dmu020. Epub 2014 May 12.
7
The physiology and clinical utility of anti-Mullerian hormone in women.抗苗勒管激素在女性中的生理学和临床应用。
Hum Reprod Update. 2014 May-Jun;20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14.
8
Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.LH 诱导的抗苗勒管激素受体表达下调的丧失可能导致多囊卵巢综合征妇女排卵障碍。
Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14.
9
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.多囊卵巢综合征女性在正常血糖高胰岛素钳夹试验中存在固有胰岛素抵抗。
Hum Reprod. 2013 Mar;28(3):777-84. doi: 10.1093/humrep/des463. Epub 2013 Jan 12.
10
Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?血浆抗苗勒管激素(AMH)水平与多囊卵巢综合征和非多囊卵巢综合征妇女的体重及代谢和激素紊乱有关吗?
Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):254-9. doi: 10.1016/j.ejogrb.2011.06.006. Epub 2011 Jul 12.

抗苗勒管激素诊断界值在中国女性多囊卵巢综合征中的应用。

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.

机构信息

Department of Laboratory Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Department of Ultrasound, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

出版信息

PLoS One. 2018 Aug 28;13(8):e0203129. doi: 10.1371/journal.pone.0203129. eCollection 2018.

DOI:10.1371/journal.pone.0203129
PMID:30153296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6112651/
Abstract

OBJECTIVE

We intended to establish the threshold for anti-Mullerian hormone (AMH) in the diagnosis of polycystic ovary syndrome (PCOS) in China.

METHODS

A total of 771 women (653 with PCOS and 118 healthy controls) were enrolled. The serum AMH, follicle-stimulating hormone (FSH), luteinizing hormone (LH), FSH/LH, prolactin, estradiol, testosterone (T), dehydroepiandrosterone sulfate (DHEA-S), sex hormone-binding globulin (SHBG), 17α-OH progesterone (17α-OHP), fasting insulin (INS), fasting glucose, free androgen index (FAI%) and homeostasis model assessment for insulin resistance (HOMA-IR) index were analyzed, and the diagnostic utility of AMH, LH/FSH, T and INS was established using receiver operator characteristic (ROC) curves. With AMH, LH/FSH, T and INS as independent variables, a logistic regression model was established, and the ROC curve for combined detection was fitted with the probability value of the model.

RESULTS

The serum level of FSH, LH, LH/FSH, AMH, FAI%, 17α-OHP, fasting INS, T, SHBG, DHEA-S and HOMA-IR were altered in the PCOS patients. The best compromise between sensitivity and specificity was found at an AMH cut-off level of 8.16 ng/ml and 5.89 ng/ml for the age groups 20-29 and 30-39 years, with the corresponding area under the curve being 0.846 and 0.865 respectively. The area under the ROC curve for combined detection was 0.951, which was significantly greater than that of each index. Finally, the concentration of AMH was associated with FSH, LH, LH/FSH, T, and ovarian volume in PCOS patients.

CONCLUSION

The optimal AMH diagnostic threshold for PCOS was 8.16 ng/ml (20-29 years) and 5.89 ng/ml (30-39 years) in the Chinese population of this study. Moreover, serum AMH, LH/FSH, T and INS could be used in combination to improve the diagnostic specificity and sensitivity for the detection of PCOS.

摘要

目的

本研究旨在建立中国人抗苗勒管激素(AMH)诊断多囊卵巢综合征(PCOS)的界值。

方法

共纳入 771 名女性(653 名 PCOS 患者和 118 名健康对照者)。检测血清 AMH、卵泡刺激素(FSH)、黄体生成素(LH)、LH/FSH、催乳素、雌二醇、睾酮(T)、硫酸脱氢表雄酮(DHEA-S)、性激素结合球蛋白(SHBG)、17α-羟孕酮(17α-OHP)、空腹胰岛素(INS)、空腹血糖、游离雄激素指数(FAI%)和胰岛素抵抗稳态模型评估(HOMA-IR)指数,并采用受试者工作特征(ROC)曲线分析 AMH、LH/FSH、T 和 INS 的诊断效能。以 AMH、LH/FSH、T 和 INS 为自变量建立 logistic 回归模型,拟合模型概率值的联合检测 ROC 曲线。

结果

PCOS 患者血清 FSH、LH、LH/FSH、AMH、FAI%、17α-OHP、空腹 INS、T、SHBG、DHEA-S 和 HOMA-IR 水平发生改变。在 20-29 岁和 30-39 岁年龄组中,AMH 截断值分别为 8.16ng/ml 和 5.89ng/ml 时,灵敏度和特异性达到最佳平衡,对应的曲线下面积分别为 0.846 和 0.865。联合检测的 ROC 曲线下面积为 0.951,显著大于各指标。最后,PCOS 患者 AMH 浓度与 FSH、LH、LH/FSH、T 和卵巢体积相关。

结论

本研究中中国人群的 PCOS 最佳 AMH 诊断界值为 8.16ng/ml(20-29 岁)和 5.89ng/ml(30-39 岁)。此外,血清 AMH、LH/FSH、T 和 INS 联合使用可提高 PCOS 检测的诊断特异性和灵敏度。